Companies: 10,795·Total market cap: $144.5T
Arcadia Biosciences, Inc.

Arcadia Biosciences, Inc.

RKDANASDAQBasic Materials● Active
$0.92
$-0.15(-13.57%)
Market Cap$1430959
P/E Ratio
52W High$6.71
52W Low$0.8
Overview

Arcadia Biosciences, Inc. (RKDA) Stock Overview

Key statistics and deep links to earnings, valuation, revenue, dividends, and more.

FMP · RKDA · as of Jun 9, 2026

Key Statistics

EPS (TTM)$-6.82rkda eps ttm · rkda earnings per shareEarnings history
PE Ratio (TTM)rkda pe ratio ttm · rkda price to earningsPE Ratio deep dive
Revenue (TTM)$4.8Mrkda revenue ttm · rkda annual revenueFull revenue history
Dividend YieldNo Dividenddoes rkda pay dividends · rkda dividend yieldDividend history
Shares Outstanding1.4Mrkda shares outstanding · rkda floatShares outstanding history
Next EarningsAug 19, 2026Est.rkda earnings date · rkda next earningsEarnings history

Financial Snapshot

Full Financials
FY 2025Revenue$4.9M▼ 3.71% YoY
202320242025
arcadia biosciences, inc. revenue · rkda revenue 2025
FY 2025Net Income-$2.3M▲ +66.77% YoY
202320242025
arcadia biosciences, inc. net income · rkda profit 2025
FY 2025EPS$-1.71▲ +66.86% YoY
202320242025
rkda eps · arcadia biosciences, inc. earnings per share 2025
TTM:Revenue: $4.8MNet Income: -$9.3MEPS: $-6.82View income statement →

Analyst Ratings & Price Target

Full Forecast
SellBuy
Buy5 analystsis rkda a buy · rkda analyst rating
Strong Buy
0
Buy
4
Hold
1
Sell
0
Strong Sell
0
12-Month Price Target
$6.00Low
$0.92Current
$6.00Avg Target548.79% upside
$6.00High
rkda price target · rkda 12 month forecast

Total: 5 · Buy rate: 80.0%

The RKDA analyst consensus is Buy, based on ratings from 5 Wall Street analysts over the past 3 months. The average 12-month price target is $6.00, representing +548.79% upside from the current price of $0.92.

Stock Performance

Full History
1D-14.46%
1W-4.35%
1M-14.46%
3M-53.54%
YTD-53.77%
1Y-81.69%
5Y-99.21%

About Arcadia Biosciences, Inc.

CEOThomas J. Schaefer
IPO DateMay 15, 2015
Employees9
CountryUS

Arcadia Biosciences, Inc. is a U.S.-based company that provides plant-derived health and well-being products. Additionally, it is actively engaged in agricultural research and development, with a part…

what is arcadia biosciences, inc. · rkda stock overview · arcadia biosciences, inc. company profile · who is arcadia biosciences, inc. ceo · rkda NASDAQ · arcadia biosciences, inc. headquarters · arcadia biosciences, inc. business segments

About Stock Overview & Key Data

Arcadia Biosciences, Inc. (RKDA) is a Basic Materials company in the Agricultural Inputs industry, listed on NASDAQ since May 15, 2015. As of the latest trading session, RKDA stock price is $0.92, with a market capitalization of $1.4M. The stock has returned -81.69% over the past 12 months and -53.77% year-to-date.

According to 5 Wall Street analysts, the consensus rating for Arcadia Biosciences, Inc. stock is Buy, with an average 12-month price target of $6.00. In fiscal year 2025, Arcadia Biosciences, Inc. reported revenue of $4.9M and net income of -$2.3M. For detailed data — including Arcadia Biosciences, Inc. revenue history, earnings, dividends, and PE ratio — use the tabs above.

Frequently Asked Questions

As of the latest trading session, Arcadia Biosciences, Inc. (RKDA) stock price is $0.92. The stock is traded on NASDAQ under the ticker symbol RKDA. The 52-week range is $0.80 – $6.71.

RKDA stock priceRKDA quote todaylive ticker
Data provided by Financial Modeling PrepLast updated: Jun 9, 2026Not investment advice